Press release
United States 7MM Digital Therapeutics for Diabetes Market to hit US$ 2,578.46 million by 2033 | Major Companies 2025 - Welldoc, Inc., Omada Health Inc., Glooko, Inc., Azumio Inc., Abbott Laboratories
7MM Digital Therapeutics for Diabetes Market
Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/7mm-digital-therapeutics-for-diabetes-market?sp
United States
Recent Launches and Investments
✅ In July 2025, Omada Health launched a digital therapeutics program for diabetes management integrating AI-driven lifestyle coaching. The platform monitors glucose levels and provides personalized recommendations. It targets patients aiming to improve glycemic control and overall health.
✅ In March 2025, Livongo (Teladoc Health) introduced an upgraded diabetes digital platform with real-time data tracking and predictive analytics. The solution is supported by $20 million in venture investment. It enhances patient engagement and clinical outcomes.
Mergers and Acquisitions
✅ In August 2025, Roche partnered with a U.S. digital health startup to co-develop next-generation diabetes digital therapeutics. The collaboration focuses on AI-enabled glucose management. It strengthens Roche's digital health and patient support portfolio.
✅ In May 2025, Johnson & Johnson acquired a minority stake in a diabetes digital therapeutics company to expand its remote patient monitoring capabilities. The acquisition enhances R&D and integration of digital care solutions. It targets improved adherence and outcomes.
Japan
Recent Launches and Investments
✅ In July 2025, Omron Healthcare launched a digital therapeutics program for diabetes management using connected devices and mobile apps. The platform offers personalized coaching and real-time monitoring. It targets Japanese patients with type 2 diabetes.
✅ In March 2025, Takeda Pharmaceutical introduced a mobile-based diabetes management solution integrated with wearable glucose monitors. The program supports lifestyle modification and medication adherence. It aims to improve glycemic control and patient engagement.
Mergers and Acquisitions
✅ In August 2025, Sumitomo Pharma partnered with a U.S. digital therapeutics startup to co-develop AI-driven diabetes management solutions. The collaboration focuses on adaptive therapy guidance and patient support. It strengthens Japan's digital health landscape.
✅ In May 2025, Mitsubishi Tanabe Pharma acquired a domestic diabetes digital therapeutics company to expand its remote care offerings. The acquisition supports R&D in personalized digital treatment. It targets improved patient outcomes and chronic disease management.
7MM Digital Therapeutics for Diabetes Market: Drivers
The digital therapeutics market for diabetes in the 7MM is experiencing strong growth as healthcare systems increasingly adopt technology-driven solutions for disease management and patient engagement. Rising prevalence of type 1 and type 2 diabetes is driving demand for personalized, data-driven interventions that improve glycemic control and overall health outcomes. Technological advancements, including AI, machine learning, continuous glucose monitoring (CGM), and predictive analytics, are enabling highly individualized treatment plans and real-time patient monitoring. Supportive regulatory frameworks and reimbursement policies across the 7MM countries are facilitating wider adoption of digital therapeutics. With growing focus on remote patient care, preventive healthcare, and cost-effective disease management, digital therapeutics for diabetes are becoming a key component of modern healthcare delivery.
Integration of digital therapeutics with mobile applications, wearable devices, and telemedicine platforms is enhancing patient engagement, adherence, and clinical outcomes. Expansion of clinical validation studies and evidence-based programs is building trust and accelerating adoption among healthcare providers. Marketing strategies emphasizing convenience, personalized care, and measurable health benefits are increasing awareness among patients and physicians. Rising demand for chronic disease management solutions that reduce hospitalizations and healthcare costs is further driving market growth. As global focus on digital health and patient-centered care continues to rise, the digital therapeutics market for diabetes in the 7MM is poised for sustained growth and innovation.
Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/7mm-digital-therapeutics-for-diabetes-market?sp
7MM Digital Therapeutics for Diabetes Market: Major Players
Welldoc, Inc., Omada Health Inc., Glooko, Inc., Azumio Inc., Abbott Laboratories, mySugr GmbH, Dexcom, Inc., Health2Sync, iHealth Labs Inc. and Medtronic plc and among others.
Segment Covered in the 7MM Digital Therapeutics for Diabetes Market:
➥ By Product Type: Software Solutions, Hardware Solutions
➥ By Application: Type-1 Diabetes, Type-2 Diabetes, Pre-Diabetes
➥ By End-User: Hospitals, Specialty Clinics, Homecare Settings, Others
Research Process:
Both primary and secondary data sources have been used in the 55 Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Most Frequently Asked Questions in the 7MM Digital Therapeutics for Diabetes Market Research Industry:
➠ Who leads the 7MM Digital Therapeutics for Diabetes industry and what's their competitive positioning regarding capacity, performance, and profitability?
➠ What growth opportunities and market challenges do 7MM Digital Therapeutics for Diabetes market vendors face?
➠ Which segments show the highest growth potential and market share distribution?
➠ What factors are driving or limiting 7MM Digital Therapeutics for Diabetes market growth?
➠ What are the dominant sales and distribution strategies in the 7MM Digital Therapeutics for Diabetes industry?
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=7mm-digital-therapeutics-for-diabetes-market
Regional Analysis:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp
✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends
Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States 7MM Digital Therapeutics for Diabetes Market to hit US$ 2,578.46 million by 2033 | Major Companies 2025 - Welldoc, Inc., Omada Health Inc., Glooko, Inc., Azumio Inc., Abbott Laboratories here
News-ID: 4179201 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
United States Legal AI Software Market to Reach USD 3.7 Billion by 2030, Driven …
The global Legal AI Software Market reached USD 0.5 billion in 2022 and is projected to reach USD 3.7 billion by 2030, growing at a CAGR of 28.7% during the forecast period 2024-2031, according to DataM Intelligence.
United States: Recent Industry Developments
✅ In September 2025, Thomson Reuters launched its next-generation AI contract review platform, reducing document analysis time by 80% for corporate legal teams.
✅ In August 2025, A coalition of top…
United States AI In Renewable Energy Market to Reach USD 4.85 Billion by 2032, D …
The global AI In Renewable Energy Market reached US$ 0.85 billion in 2024 and is projected to reach US$ 4.85 billion by 2032, growing at a CAGR of 24.32% during the forecast period 2025-2032, according to DataM Intelligence.
United States: Recent Industry Developments
✅ In September 2025, The National Renewable Energy Laboratory (NREL) launched an AI platform that improved solar generation forecasts by 30%, significantly enhancing grid reliability.
✅ In August 2025,…
United States AI In Energy Market Projected to Expand at 33.45% CAGR, Reaching U …
The global AI In Energy Market reached US$ 9.89 billion in 2024 and is projected to reach US$ 99.48 billion by 2032, growing at a CAGR of 33.45% during the forecast period 2025-2032, according to DataM Intelligence.
United States: Recent Industry Developments
✅ In September 2025, Google DeepMind partnered with a major US utility to implement AI for real-time grid optimization, reducing energy losses by 15%.
✅ In…
United States Allergy Immunotherapies Market 2025 | Growth Drivers, Trends & Mar …
Market Size and Growth
The "Global Allergy Immunotherapies Market" is predicted to reach at a high CAGR of 10.4% during the forecast period (2022-2029)
Key Development:
United States: Recent Industry Developments
✅ In September 2025, Sanofi expanded its allergy immunotherapy portfolio by acquiring Ayvakit and early-stage immunology assets for USD 9.1 billion, enhancing its position in severe allergic conditions.
✅ In June 2025, BioVaxys Technology Corp. launched a private placement to raise USD 1.2-1.6…
More Releases for Diabetes
Major Force in the Diabetes Pen Market 2025: Diabetes Fuels Surge In Demand For …
How Will the Diabetes Pen Market Grow, and What Is the Projected Market Size?
The diabetes pen market is projected to grow from $29.24 billion in 2024 to $31.22 billion in 2025, at a CAGR of 6.8%. Growth is fueled by the rising need for managing diabetes, advancements in diabetes care, and an increasing focus on patient-friendly medication administration tools.
The diabetes pen market is projected to grow strongly, reaching $40.17 billion…
Diabetes Monitoring Devices Market: Regaining Its Glory| Ascensia Diabetes Care, …
The Latest Study Published by HTF MI Research on the "Diabetes Monitoring Devices Market'' evaluates market size, trend and forecast to 2029. The Diabetes Monitoring Devices market study includes significant research data and evidences to be a practical resource document for managers and analysts is, industry experts and other key people to have an easily accessible and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges…
Prevalence of Diabetes Drives Opportunities for Type-2 Diabetes Market
The Type-2 Diabetes Market Analysis, 2023, by MarkNtel Advisors, presents a well-researched, detail-driven, and accurate study for the stakeholders. This analysis entails prominent aspects like trends, & recent developments, drivers, opportunities, challenges, & restraints, among other parameters, influencing the overall industry expansion across different locations. This report comprises data from historic years (2018-21) & the base year (2022) to put together an estimation of the forecast period (2023-28).
According to Type-2 Diabetes Market…
Reverse Diabetes with Dr. Merritt’s Diabetes Reversal Recipe
[November 26, 2020] – People suffering from diabetes always search for ways to lower blood sugar levels in their bodies. Diabetes treatment available costs you hundreds of dollars yearly and also restricts you to a diabetic diet. That hampers your mental health and well-being. Apart from this, eye problems, kidney failure, amputations are some of the physical problems diabetic patients face.
Dr. Marlene Merritt (from the Merritt Wellness Center in…
Diabetes Treatment
Diabetes Treatment is a important way to help manage the healthy ,easy to use and improve the way of the treatment of blood glucose monitoring system.
As living standards improve, an increasing obesity, the Diabetes Treatment has improved peoples living habits, disease control effect, is becoming more and more important.
The global Diabetes Treatment market is valued at 43700 million US$ in 2018 and will reach 58000 million US$ by the end…
Self-Monitoring Blood Glucose Devices Market Study by Advance Application [Type …
The global self-monitoring blood glucose devices market was valued at $7,768 million in 2017 and is projected to reach $10,828 million by 2025 at a CAGR of 4.2% from 2018 to 2025. Monitoring of blood glucose is an essential step in diabetes management. Blood glucose monitoring devices are predominantly used to monitor a patient’s blood glucose level. Self-monitoring blood glucose (SMBG) devices are easy-to-use and enable people to monitor their…
